| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-13 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-10 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-10 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.2 | 5e-09 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-08 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |